ViroCell Biologics

ViroCell Biologics is a contract development and manufacturing organization (CDMO) specializing in GMP viral vector manufacturing for clinical trials in cell and gene therapy. They offer a full range of pre-clinical and clinical viral vector services to accelerate the clinical development of novel CGTs, focusing on lentivirus and gamma-retrovirus vectors. ViroCell aims to be the partner of choice for companies developing cell and gene therapies.

Buy Funded Startups lists

Funding Round: Convertible Note

Funding Amount:

Date: 14-Aug-2024

Investors: First Light Asset Management LLC, Sartorius Stedim Biotech S.A., Dorset Opportunity Fund LP

Markets: Cell and Gene Therapy, Biotechnology, CDMO

HQ: London, England, United Kingdom

Founded: 2020

Website: https://virocell.com

LinkedIn: https://uk.linkedin.com/company/virocell-biologics

Twitter:

Instagram: